Integrating Treatment Protocols and Community Pharmacy in HE Management

Arun Jesudian, MD; Ralph J. Riello, PharmD, BCPS, and Chas McCormick, RPh, MBA, highlight the crucial role of pharmacies in providing unbiased patient education. They also emphasize the significance of incorporating treatment protocols into medical health records and utilizing various tools to optimize the success of hepatic encephalopathy treatment.

EP: 1.Identifying and Screening for Hepatic Encephalopathy Risk Factors

EP: 2.Achieving Post-Discharge Success: Goals in Hepatic Encephalopathy Care

EP: 3.Implementing Evidence-Based Guidelines for Hepatic Encephalopathy Management

EP: 4.Addressing the Caregiver Burden in Hepatic Encephalopathy Management

EP: 5.Optimizing Care for Newly Diagnosed Hepatic Encephalopathy

EP: 6.Enhancing Hepatic Encephalopathy Care through Pharmacist-Prescriber Collaboration

EP: 7.Managing Adverse Events Associated with HE Therapies

Now Viewing

EP: 8.Integrating Treatment Protocols and Community Pharmacy in HE Management

EP: 9.Promoting Adherence: Strategies for Maintaining HE Therapy

EP: 10.Empowering Pharmacists: Essential Insights for HE Management

EP: 11.Optimizing Transitions of Care for Hepatic Encephalopathy Patients

EP: 12.Collaborative Care: Key Stakeholders in HE Treatment and Recovery

EP: 13.Hepatic Encephalopathy: Critical Insights and Closing Thoughts

Related Videos

Related Content

Advertisement

March 4th 2024

Integration of DBS Shows Promise Identifying Dysfunctional Brain Circuits, Treating Brain Disorders

Gillian McGovern, Assistant Editor

December 20th 2024

Examining the 505(b)(2) Pathway and Implementation into EHR

Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA

January 22nd 2024

Study Findings Suggest Liver Creates Palmitic Acid, Maintaining Brain Health

Gillian McGovern, Assistant Editor

January 15th 2024

Individuals With Obesity More Likely to Have MGUS, A Multiple Myeloma Precursor

Gillian McGovern, Assistant Editor

January 9th 2024

FDA Accepts sBLA for Tisotumab Vedotin-tftv for the Treatment of Recurrent, Metastatic Cervical Cancer

Gillian McGovern, Assistant Editor

January 9th 2024

Study Data Show Telemedicine Endocrinology Care Not as Effective as In-Person Care

Erin Hunter, Associate Editor

Related Content

Advertisement

March 4th 2024

Integration of DBS Shows Promise Identifying Dysfunctional Brain Circuits, Treating Brain Disorders

Gillian McGovern, Assistant Editor

December 20th 2024

Examining the 505(b)(2) Pathway and Implementation into EHR

Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA

January 22nd 2024

Study Findings Suggest Liver Creates Palmitic Acid, Maintaining Brain Health

Gillian McGovern, Assistant Editor

January 15th 2024

Individuals With Obesity More Likely to Have MGUS, A Multiple Myeloma Precursor

Gillian McGovern, Assistant Editor

January 9th 2024

FDA Accepts sBLA for Tisotumab Vedotin-tftv for the Treatment of Recurrent, Metastatic Cervical Cancer

Gillian McGovern, Assistant Editor

January 9th 2024

Study Data Show Telemedicine Endocrinology Care Not as Effective as In-Person Care

Erin Hunter, Associate Editor